MarginsXMarginsX
Home › Markets › Health Care › RLX

RLX Technology Inc. (RLX)

RLX trades on NYSE in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.53
-1.92% on the day
Market cap
$1.9B
Small cap
Revenue · 2025
$566.1M
+50.3% on 2024
Net income · 2025
$131.8M
23.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1828365/000110465926047278/0001104659-26-047278-index.htm. Net income: SEC 20-F (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerRLX on NYSE
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryCayman Islands
IPO year2021
SEC CIK0001828365
SEC industry codeCigarettes
Incorporated inCayman Islands

Financials · 2025

LineValue
Revenue$566.1M
Net income$131.8M
Operating income$47.0M
Net margin23.3%
Operating margin8.3%
Revenue growth+50.3%
Cash$767.5M
Total assets$2.6B
P/E (computed)14.2×
P/S (computed)3.3×

Warning signs

Cash runway
Cash-flow positive
$767.5M cash at December 31, 2025
Share count, 1 year
See the dilution note
-1.4% over 3 years
Going-concern doubt
No
20-F filed April 23, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-04-23
Cash and burn$767.5M cash; operating cash flow $39.5M a quarter.Report 2025-12-31
Shares outstandingNo cover-page share count in XBRLCover page 2026-03-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers Zhong Tian LLP, Beijing, ChinaPCAOB Form AP 2026-05-25
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$566.1M$131.8M$157.9M$767.5M$13.2M$566.1M20-F 2026-04-23
FY 2024
2024-12-31
$376.6M$75.6M$117.0M$766.3M$5.5M$376.6M20-F 2025-04-17
FY 2023
2023-12-31
$223.4M$75.3M$28.0M$336.7MNo debt tags$223.4M20-F 2024-04-19
FY 2022
2022-12-31
$773.2M$209.0M$70.6M$183.9MNo debt tags$773.2M20-F 2023-04-21
FY 2021
2021-12-31
$1.3B$317.7M$282.4M$817.4MNo debt tags$1.3B20-F 2022-04-29
FY 2020
2020-12-31
$585.4M-$19.6M$396.8M$170.7MNo debt tags$585.4M20-F 2021-04-23

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42021-01-22
Latest annual report20-F2026-04-23
Latest quarterly / interim
FORM 6-K
6-K2026-08-14

Source: SEC EDGAR submissions feed, 88 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-3.1%
1 month-8.8%
3 months-22.0%
Year to date-33.0%
1 year-33.0%
From 52-week high-39.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
TRLVTrulieve Cannabis Corp. Subordinate Voting Shares$10.33-5.23%$2.0B
RGCRegencell Bioscience Holdings Limited$4.72-4.45%$2.3B
CRONCronos Group Inc. Common Share$3.27-3.25%$1.2B
DFTXDefinium Therapeutics Inc. Common Shares$30.16-5.99%$4.1B
OBIOOrchestra BioMed Holdings Inc.$7.12-1.79%$560.4M
TLRYTilray Brands Inc. Common Stock$2.34-3.70%$345.8M
SNDLSNDL Inc. Common Shares$1.34-2.19%$326.0M
ACBAurora Cannabis Inc. Common Shares$4.61-6.68%$303.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier